NIRVF (Nirvana Life Sciences) Common Stock: $5.72 Mil (As of Jan. 2026)


What is Nirvana Life Sciences Common Stock?

Nirvana Life Sciences NIRVF Common Stock is $5.72 Mil as of Jan. 2026. The stock has 3 warning signs investors should review.

Nirvana Life Sciences's quarterly common stock declined from Jul. 2025 ($5.76 Mil) to Oct. 2025 ($4.95 Mil) but then increased from Oct. 2025 ($4.95 Mil) to Jan. 2026 ($5.72 Mil).

Nirvana Life Sciences's annual common stock increased from Apr. 2023 ($4.73 Mil) to Apr. 2024 ($5.06 Mil) but then declined from Apr. 2024 ($5.06 Mil) to Apr. 2025 ($4.95 Mil).

Nirvana Life Sciences Common Stock Historical Data

* Premium members only.

The historical data trend for Nirvana Life Sciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nirvana Life Sciences Common Stock Chart

Nirvana Life Sciences Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Apr22 Apr23 Apr24 Apr25
Common Stock
Get a 7-Day Free Trial 4.35 4.74 4.73 5.06 4.95

Nirvana Life Sciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.81 4.95 5.76 4.95 5.72

Nirvana Life Sciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $5.72 Mil mean?
Nirvana Life Sciences (NIRVF) has a Common Stock of $5.72 Mil as of Jan. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Nirvana Life Sciences and its competitors.
Is Nirvana Life Sciences' Common Stock too high?
Nirvana Life Sciences' current Common Stock is $5.72 Mil.
How does Nirvana Life Sciences' Common Stock compare to VRTX and REGN?
Nirvana Life Sciences' Common Stock of $5.72 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Nirvana Life Sciences and its competitors. Nirvana Life Sciences's current Common Stock is $5.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nirvana Life Sciences stock overvalued right now?
Nirvana Life Sciences (NIRVF) has a current Common Stock of $5.72 Mil. The current Common Stock is $5.72 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Nirvana Life Sciences (NIRVF), the current Common Stock is $5.72 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nirvana Life Sciences Business Description

Other Exchanges NIRV.X:Canada
Address 650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of therapeutic products derived from psychedelics. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.